Exela Technologies, Inc. Announces Appointment of Martin Akins to Board of Directors
July 29 2019 - 8:15AM
Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA),
a location-agnostic global business process automation (“BPA”)
leader across numerous industries, announced that effective today,
Martin “Marty” P. Akins, formerly SVP, General Counsel of Express
Scripts Holding Company, has been appointed to Exela’s board of
directors.
“Marty’s significant public company experience,
serving as general counsel, provides him with great perspective on
a number of items including governance, the regulatory environment,
and mergers and acquisitions. We conducted a thorough search for
someone who would further strengthen the talent, wisdom and varied
background of our board, and Marty is a great addition,” said Par
Chadha, Chairman of the Board of Exela.
“I am honored to join the board of Exela and I
look forward to offering my perspective and experience learned
through my time at Express Scripts Holding Company in helping guide
Exela’s continued growth. With 18 years of boardroom exposure, I
look forward to adding my experience in mergers and acquisitions,
regulation, succession planning, governance and more to the current
Exela board,” said Akins.
Mr. Akins most recently worked at publicly
traded Express Scripts Holding Company, a Fortune 25 company and
the largest independent pharmacy benefit management company in the
United States. In December of 2018, the Company merged with Cigna.
As Senior Vice President and General Counsel, at Express Scripts
Holding Company he served as the chief legal advisor and was also a
member of Express Scripts’ senior executive team where he advised
the CEO and outlined strategy to the Board of Directors. He was at
Express Scripts Holding Company from 2001 through 2019, serving in
various legal capacities including VP, Deputy General Counsel and
Associate General Counsel. Prior to his time at Express Scripts,
Mr. Akins was with the Polsinelli law firm. Akins began his legal
career with the firm Thompson Coburn LLP. He received his Juris
Doctorate from the University of Illinois College of Law.
Mr. Akins has been appointed to serve as a
member of Exela’s Audit Committee and Nominating and Corporate
Governance Committee. With his appointment the board now has 8
directors. Mr. Akins will serve as a Class C director and will
stand for election at the 2020 annual meeting of stockholders of
the Company.
About Exela Exela is a business
process automation (BPA) leader, leveraging a global footprint and
proprietary technology to provide digital transformation solutions
enhancing quality, productivity, and end-user experience. With
decades of expertise operating mission-critical processes, Exela
serves a growing roster of more than 4,000 customers throughout 50
countries, including over 60% of the Fortune® 100. With
foundational technologies spanning information management, workflow
automation, and integrated communications, Exela’s software and
services include multi-industry department solution suites
addressing finance and accounting, human capital management, and
legal management, as well as industry-specific solutions for
banking, healthcare, insurance, and public sectors. Through
cloud-enabled platforms, built on a configurable stack of
automation modules, and over 22,000 employees operating in 23
countries, Exela rapidly deploys integrated technology and
operations as an end-to-end digital journey partner.Find out more
at www.exelatech.com
Follow Exela on
Twitter: https://twitter.com/exelatechFollow
Exela on
LinkedIn: https://www.linkedin.com/company/11174620/
Contact: Jim MathiasE: ir@exelatech.comW:
investors.exelatech.comT: +1 972-821-5808
Exela Technologies (NASDAQ:XELA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exela Technologies (NASDAQ:XELA)
Historical Stock Chart
From Apr 2023 to Apr 2024